American Society of Hematology, 2025 (ASH)7 - 9 December 2025
Modified-Release Formulation of Decitabine and Tetrahydrouridine Combination Not Only Increases Exposure to Decitabine but Reduces Exposure to Unfavorable Decitabine Metabolites in Healthy Volunteers
Sorry! It looks like the page you are trying to access contains materials that are still under embargo. Please come back and check again later.